Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 14, 2008ACUITY® Steerable lead also receives reimbursement approval; Company plans to launch product immediately
Boston Scientific Corporation (NYSE: BSX) today announced Japanese Ministry of Health, Labor and Welfare (MHLW) approval of its ACUITY® Steerable...
-
Apr 7, 2008
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31,...
-
Apr 7, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the appointment of Timothy Pratt as its new General Counsel. Pratt is a nationally...
-
Apr 2, 2008Judgment entered in favor of Guidant and its former directors/officers
Boston Scientific Corporation (NYSE: BSX) today announced that United States District Judge Sarah Evans Barker, Indianapolis, dismissed...
-
Apr 1, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from a pooled analysis of patients from its TAXUS IV and TAXUS...
-
Apr 1, 2008Results from TAXUS IV and V randomized clinical trials favor DES compared to bare-metal stents
Boston Scientific Corporation (NYSE: BSX) today welcomed favorable outcomes of one- year data from the Company's TAXUS IV and V...
-
Mar 31, 2008At two years, Company's TAXUS® and PROMUS™ Stents demonstrate positive and similar outcomes
Boston Scientific Corporation (NYSE: BSX) today welcomed positive two-year results from Abbott's prospective, randomized (3:1), single...
-
Mar 31, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the sale of Boston Scientific Santa Rosa Corp., formerly known as TriVascular, Inc., to...
-
Mar 29, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of two-year data from more than 7,000 patients in...
-
Mar 29, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of 4,772 patients from its TAXUS ARRIVE 1 and 2...
-
Mar 25, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements at the Society for...
-
Mar 11, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Lehman Brothers Health Care Conference, which is being held March 18...
-
Mar 3, 2008ACUITY® Spiral lead offers flexibility for placement in small, medium and large veins
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of its ACUITY® Spiral left ventricular lead for use with cardiac...
-
Feb 28, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the first European implants of its COGNIS™ cardiac resynchronization therapy...
-
Feb 26, 2008Dr. Jay Schnitzer to join the Company
Boston Scientific Corporation (NYSE: BSX) today announced that Jay J. Schnitzer, M.D., Ph.D. will be joining the Company's Clinical Sciences...
-
Feb 25, 2008Approvals include CONFIENT™ ICD, LIVIAN™ CRT-D and upgraded LATITUDE® Patient Management System
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval for three products in its Cardiac Rhythm...
-
Feb 14, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of its Fluid Management and Venous Access businesses to...
-
Feb 12, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that a U.S. District Court jury in Marshall, Texas has reached a verdict in a patent...
-
Feb 11, 2008PROENCY will provide real-world clinical data on the PROMUS™ Stent
Boston Scientific Corporation (NYSE: BSX) today announced that the first patient has been enrolled in its PROENCY (PROMUS™, ENdeavor® and...
-
Feb 4, 2008
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the fourth quarter and full year ended December 31, 2007, as well as...
-
Feb 4, 2008'Close the Gap' brings together advocates from cardiologists to coaches
Boston Scientific Corporation (NYSE: BSX) today announced the public debut of an educational initiative called "Close the Gap," which is aimed at...
-
Jan 30, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical...
-
Jan 23, 2008
Boston Scientific (NYSE: BSX) today issued the following statement from Donald S. Baim, M.D., Chief Medical and Scientific Officer, on an article in the New...
-
Jan 23, 2008
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter and the year ended...
-
Jan 22, 2008
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval for its COGNIS™ cardiac resynchronization therapy defibrillator...